AMELIA FRAZIER: Open Payments
NPI 1750728580 · GUNTERSVILLE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,242 in 109 payments from 21 companies in 2025. Trend: 2023 $17 · 2024 $821 · 2025 $2,242
Food & beverage: $2,067Education: $175
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 35 | $568 |
| Novartis Pharmaceuticals Corporation | 23 | $325 |
| GENZYME CORPORATION | 10 | $206 |
| Organon LLC | 2 | $139 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $110 |
| Lilly USA, LLC | 4 | $108 |
| SANOFI-AVENTIS U.S. LLC | 1 | $90 |
| LEO Pharma Inc. | 4 | $87 |
| UCB, Inc. | 3 | $77 |
| Galderma Laboratories, L.P. | 3 | $70 |
Products named: RINVOQ, DUPIXENT, COSENTYX, SKYRIZI, VTAMA, EBGLYSS, Bimzelx, ADBRY.
Industry payments across AL — which companies pay providers there.
